New hope for Alzheimer's? phase 3 trial of brain-fueling compound begins
Disease control
Not yet recruiting
This study tests whether a daily dose of tricaprilin, a type of fat that may provide energy to brain cells, can improve memory, thinking, and daily function in people with mild-to-moderate Alzheimer's disease. About 535 participants will receive either tricaprilin or a placebo fo…
Phase: PHASE3 • Sponsor: Cerecin • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC